Pfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal - NBC News

Pfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal  NBC NewsLyme disease vaccine shows 70 percent efficacy, Pfizer says  The Washington PostPfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss  CNBCPfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push  Fierce BiotechPfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial  MarketWatch